Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 22Terminated 17Active not recruiting 14Recruiting 10Withdrawn 7Unknown 4Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 8Genitourinary 4Thoracic 3Tumor-Agnostic 2Sarcoma 2Other solid neoplasm 2Lymphoid 2Head & Neck 2Dermatologic 2Breast 2Other hematologic neoplasm 1Gynecologic 1CNS 1

Conditions

Carcinoma, Renal Cell 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Penile Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Mesothelioma, Malignant 1Melanoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Docetaxel 33Radiosurgery 23Radiotherapy 21Sunitinib 20pembrolizumab 18Gemcitabine 16Cisplatin 16Androgen Antagonists 15Nivolumab 14enzalutamide 13Goserelin 13Prednisone 12Leuprolide 12Blood Specimen Collection 12Abiraterone Acetate 12bicalutamide 11aldesleukin 11Surveys and Questionnaires 11Cyclophosphamide 11Gonadotropin-Releasing Hormone 10Bevacizumab 10Multiparametric Magnetic Resonance Imaging 9Carboplatin 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Triptorelin Pamoate 8Radiotherapy, Intensity-Modulated 8Filgrastim 8Epirubicin 8Chemotherapy, Adjuvant 8Brachytherapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × avelumab × Genitourinary × Clear all
NCT03774901 2023-04-21

PULSE

Centre Hospitalier Universitaire de Besancon

Phase 2 Unknown
32 enrolled
Genitourinary

Penile Neoplasms

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Jules Bordet Institute

Phase 2 Unknown
441 enrolled
BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03950362 2019-05-16

PREVERT

Institut Paoli-Calmettes

Phase 2 Unknown
67 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03341845 2018-05-21

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

The Netherlands Cancer Institute

Phase 2 Unknown
40 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡